Complicated CONDITIONS.
Precision Gene-based Therapeutics for the CNS
Alcyone is pioneering next-generation CNS precision gene-based therapeutics for complex neurological conditions. We integrate innovation in neuroscience, precision dosing and delivery, and manufacturing capabilities to deliver transformative therapies to patients.
Alcyone leverages the synergy between Falcon™, our proprietary intrathecal precision dosing and biodistribution platform that incorporates deep knowledge of cerebral spinal fluid (CSF) dynamics, computational modeling, and bioengineering, and four novel gene-based therapeutics platforms. This comprehensive approach allows for the optimization of CNS dosing and delivery to better target the pathophysiology and anatomy specific to various neurological diseases.
Shining Brightly Together
Alcyone / Eta Tauri takes its name from the giant star within the borders of the Taurus constellation. Alcyone is not one single star, but a multiple star system with three components. Like the star, Alcyone Therapeutics combines three bright platforms of science and technology that together shine a brilliant light.
How it works
At Alcyone, we have engineered four platform technologies, across which there are several gene-based therapeutics. Each of our therapeutics is manufactured through our quality CMC process and administered to the patient by Falcon™, our novel precision delivery system.
